NL180479B - METHOD FOR THE PREPARATION OR MANUFACTURE OF MEDICINAL PRODUCTS WITH ANTI-INFLAMMATORY AND CORTICOID ACTIVITY, MEDICINES FORMED AND METHOD FOR THE PREPARATION OF 1,4-PREGNADADIA COMPOUNDS SUITABLE FOR USE AS THE PRODUCT IN ITS PROPERTIES. - Google Patents

METHOD FOR THE PREPARATION OR MANUFACTURE OF MEDICINAL PRODUCTS WITH ANTI-INFLAMMATORY AND CORTICOID ACTIVITY, MEDICINES FORMED AND METHOD FOR THE PREPARATION OF 1,4-PREGNADADIA COMPOUNDS SUITABLE FOR USE AS THE PRODUCT IN ITS PROPERTIES.

Info

Publication number
NL180479B
NL180479B NLAANVRAGE7714056,A NL7714056A NL180479B NL 180479 B NL180479 B NL 180479B NL 7714056 A NL7714056 A NL 7714056A NL 180479 B NL180479 B NL 180479B
Authority
NL
Netherlands
Prior art keywords
preparation
pregnadadia
inflammatory
manufacture
properties
Prior art date
Application number
NLAANVRAGE7714056,A
Other languages
Dutch (nl)
Other versions
NL7714056A (en
NL180479C (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of NL7714056A publication Critical patent/NL7714056A/en
Publication of NL180479B publication Critical patent/NL180479B/en
Application granted granted Critical
Publication of NL180479C publication Critical patent/NL180479C/en

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NLAANVRAGE7714056,A 1976-12-22 1977-12-19 METHOD FOR THE PREPARATION OR MANUFACTURE OF MEDICINAL PRODUCTS WITH ANTI-INFLAMMATORY AND CORTICOID ACTIVITY, MEDICINES FORMED AND METHOD FOR THE PREPARATION OF 1,4-PREGNADADIA COMPOUNDS SUITABLE FOR USE AS THE PRODUCT IN ITS PROPERTIES. NL180479C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (3)

Publication Number Publication Date
NL7714056A NL7714056A (en) 1978-06-26
NL180479B true NL180479B (en) 1986-10-01
NL180479C NL180479C (en) 1987-03-02

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7714056,A NL180479C (en) 1976-12-22 1977-12-19 METHOD FOR THE PREPARATION OR MANUFACTURE OF MEDICINAL PRODUCTS WITH ANTI-INFLAMMATORY AND CORTICOID ACTIVITY, MEDICINES FORMED AND METHOD FOR THE PREPARATION OF 1,4-PREGNADADIA COMPOUNDS SUITABLE FOR USE AS THE PRODUCT IN ITS PROPERTIES.

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
DK153494B (en) 1988-07-18
AR226806A1 (en) 1982-08-31
AT377566B (en) 1985-04-10
FI63947C (en) 1983-09-12
IL53636A0 (en) 1978-03-10
NO151826C (en) 1985-06-12
FI773825A (en) 1978-06-23
NL7714056A (en) 1978-06-26
NL180479C (en) 1987-03-02
SE7714538L (en) 1978-06-23
DK153494C (en) 1989-02-20
SE429865B (en) 1983-10-03
ATA575980A (en) 1982-04-15
SG58683G (en) 1985-01-11
DE2756550A1 (en) 1978-07-06
DK569977A (en) 1978-09-28
FR2384793A1 (en) 1978-10-20
IL53636A (en) 1983-05-15
JPS5379850A (en) 1978-07-14
PT67432A (en) 1978-01-01
MY8500082A (en) 1985-12-31
HK584A (en) 1984-01-13
JPS604198B2 (en) 1985-02-01
HU179784B (en) 1982-12-28
AT373269B (en) 1984-01-10
FR2384793B1 (en) 1981-11-13
BE862089A (en) 1978-06-20
IE45950L (en) 1978-06-22
DE2756550C2 (en) 1986-10-16
NO774359L (en) 1978-06-23
FI63947B (en) 1983-05-31
NO151826B (en) 1985-03-04
PT67432B (en) 1979-05-23
ATA909477A (en) 1983-05-15
GB1575983A (en) 1980-10-01
IE45950B1 (en) 1983-01-12
NZ186031A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
NL7514940A (en) PROCESS FOR THE PREPARATION OF AZOLYL-1 METHANS AND THEIR SALTS AND THEIR USE AS MEDICINAL PRODUCTS.
NL7607338A (en) PROCESS FOR THE PREPARATION OF 1,4-DIHYDROPYRINE DERIVATIVES WITH VASOLICULATING AND BLOOD PRESSURE-REDUCING ACTIVITY.
NL186239C (en) A PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIFLOGISTIC AND / OR ANALGETIC ACTION, AND A PROCESS FOR THE PREPARATION OF A 2-HYDROXYETHYLIDEENYCYANIC ACID ACID ANILIDE SUITABLE FOR USE IN THIS PROCESS.
NL7601823A (en) PROCEDURE FOR PREPARING 1,4-DIHYDROPYRIDINE CARBONIC ACID ARALKYL ESTERS AND THEIR USE AS MEDICINAL PRODUCTS.
NL188681C (en) MEDICINAL PRODUCT FOR IMPROVING BLOODING AND HEALING.
NL7701849A (en) PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS USING PYRETHRINOIDS.
NL7614308A (en) PROCESS FOR THE PREPARATION OF ESTER DERIVATIVES OF PHENYLAIC ACID AND USE AS A MEDICINAL PRODUCT.
NL7701909A (en) METHOD FOR THE PREPARATION OF AN ANTI-CANCER MEDICINAL PRODUCT, METHOD FOR THE PREPARATION OF THE ACTIVE COMPONENT AND THE PREPARED MEDICINAL PRODUCT.
NL7702829A (en) PROCEDURE FOR THE CONTINUOUS PREPARATION OF GERMINAL MAYONNAISE AND / OR MAYONAISE PRODUCTS.
NL167436C (en) PROCESS FOR THE PREPARATION OF 7-BETA-ACYLAMINO-7 ALFA-ALKOXYCEPHALOSPORINES AND 6-BETA-ACYLAMINO-6 ALFA-ALKOXYPENICILLIN, AND FORMED MEDICINAL PRODUCT.
NL7612200A (en) RETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACNE.
NL7709508A (en) METHODS FOR THE PREPARATION OF AMINO ALKYLIDES-AMINO-1,4-DIHYDROPYRIDINS, AND THE USE OF THESE COMPOUNDS AS A MEDICINAL PRODUCT.
NL7511927A (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT BASED ON THESE DERIVATIVES.
NL7702090A (en) PROCESS FOR THE PREPARATION OF CONDENSED 5,6-SUBSTITUATED 4-AMINOALKOXY (2) 2,3-PYRANONE COMPOUNDS AND THEIR ADDITIONAL SALTS AND INTERMEDIATE PRODUCTS AS WELL AS FORMED PHARMACEUTICAL PREPARATION.
NL7700637A (en) PROCESS FOR PREPARING GESTOGENESTERS AND MEDICINAL PRODUCTS CONTAINING THESE ESTERS.
NL7704768A (en) METHOD FOR THE PREPARATION AND USE OF PHARMACEUTICAL PRODUCTS FOR THE VETERINARY SCIENCE.
NL7704320A (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND THE MOLDED PRODUCTS OBTAINED BY THEIR USE.
NL180479C (en) METHOD FOR THE PREPARATION OR MANUFACTURE OF MEDICINAL PRODUCTS WITH ANTI-INFLAMMATORY AND CORTICOID ACTIVITY, MEDICINES FORMED AND METHOD FOR THE PREPARATION OF 1,4-PREGNADADIA COMPOUNDS SUITABLE FOR USE AS THE PRODUCT IN ITS PROPERTIES.
NL7806381A (en) PYRIDAZINYLHYDRAZONE COMPOUNDS AND METHOD FOR PREPARING THEM AS WELL AS THE USE OF THESE COMPOUNDS IN PHARMACEUTICAL PRODUCTS.
NL173525B (en) METHOD FOR THE PREPARATION OR MANUFACTURE OF A MEDICINAL PRODUCT WITH AN ANTI-CUGUST ACTIVE, AND A METHOD FOR THE PREPARATION OF A 2-AMINO-4,5,7,8-TETRAHYDRO-6H-OXAZOLO-5,4-D TO BE USED THEREIN AS ACTIVE SUBSTANCE AZEPINE.
NL7416112A (en) PROCESS FOR THE PREPARATION AND USE OF PYRIDINE DERIVATIVES.
NL7704395A (en) PROCESS FOR THE PREPARATION OF N-GLYCOSYL DERIVATIVES OF POLYEN MACROLIDE AND ITS USE AS A MEDICINAL PRODUCT.
NL7706076A (en) MEDICINAL PRODUCT WITH HETEROCYCLICAL COMPOUNDS AND METHOD FOR PREPARING HETEROCYCLICAL COMPOUNDS.
NL7511943A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON 1,2-DIPHENYLETHANOLS AND THEIR USE AS AN ANTI-IGNITION AGENT.
NL7600511A (en) PROCESS FOR THE PREPARATION OF 2-AMINO-ACEETAMI-DO- (ALPHA) -PHENYL-BENZYLIDES-AMINO ALKANOL COMPOUNDS AND THEIR USE FOR THE PREPARATION OF MEDICINAL PRODUCTS.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BATV A request for search has been withdrawn
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 971219